argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 668.00
+12.00 (1.83%)
Apr 30, 2026, 5:37 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €41.54 billion as of May 1, 2026. Its market cap has increased by 30.08% in one year.
Market Cap
41.54B
Enterprise Value
37.80B
Revenue
3.61B
Ranking
n/a
PE Ratio
40.08
Stock Price
€668.00
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 41.54B, an increase of 33,833.13%. That is a compound annual growth rate of 63.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 41.54B | -5.30% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.01B |
| Financière de Tubize | 8.71B |
| Onward Medical | 184.95M |
| Hyloris Pharmaceuticals | 135.80M |
| European Medical Solutions | 22.22M |
| Celyad Oncology | 13.92M |
| BioSenic | 1.44M |
| Oxurion NV | 337.03K |